MARKET

BIOA

BIOA

BioAge Labs Inc.
NASDAQ
20.73
+0.75
+3.75%
Pre Market: 21.67 +0.94 +4.53% 05:42 02/09 EST
OPEN
20.22
PREV CLOSE
19.98
HIGH
21.17
LOW
19.54
VOLUME
23
TURNOVER
--
52 WEEK HIGH
24.00
52 WEEK LOW
2.880
MARKET CAP
865.53M
P/E (TTM)
-10.1553
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BIOA last week (0202-0206)?
Weekly Report · 1h ago
BioAge Labs price target raised to $23 from $12 at Morgan Stanley
TipRanks · 4d ago
Morgan Stanley Reaffirms Their Hold Rating on BioAge Labs, Inc. (BIOA)
TipRanks · 4d ago
Weekly Report: what happened at BIOA last week (0126-0130)?
Weekly Report · 02/02 10:31
BioAge Labs initiated with an Overweight at Piper Sandler
TipRanks · 01/27 10:15
BioAge Labs: De-Risked NLRP3 Program and 2026 Clinical Catalysts Underpin Overweight/Buy Rating
TipRanks · 01/27 10:06
U.S. RESEARCH ROUNDUP-AMETEK, Stryker, Zimmer Biomet Holdings
Reuters · 01/27 07:49
BIOAGE LABS INC <BIOA.O>: PIPER SANDLER INITIATES COVERAGE WITH OVERWEIGHT RATING; PRICE TARGET $73
Reuters · 01/27 04:10
More
About BIOA
BioAge Labs, Inc. is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its lead product is BGE-102, a structurally novel, orally available small molecule NLRP3 inhibitor with high potency and brain penetration. In preclinical obesity models, BGE-102 resulted in weight loss as both a monotherapy and in combination with a GLP-1R agonist. Its pipeline includes novel, orally available, brain-penetrant small-molecule NLRP3 inhibitors to treat metabolic diseases and conditions driven by neuroinflammation, as well as novel APJ agonists for metabolic disorders. In preclinical obesity models, APJ agonism has demonstrated the ability to more than double the weight loss induced by a GLP-1R agonist while also restoring healthy body composition and improving muscle function.

Webull offers BioAge Labs, Inc. stock information, including NASDAQ: BIOA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BIOA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BIOA stock methods without spending real money on the virtual paper trading platform.